Recent research focusing on Retatrutide at a dosage of 30mg is shedding new light on its potential benefits. Initial findings suggest that this higher dosage may boost the drug's ability to control blood glucose, potentially offering greater outcomes for individuals with insulin resistance. Further research is underway to fully understand the long-